Ding-Wen Chen
Impact in
- Ophthalmology top 10%
- Glaucoma and retinal disorders
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Retinal Development and Disorders
- Extracellular vesicles in disease
- CRISPR and Genetic Engineering
Papers in
-
- Retinal Development and Disorders 7
- RNA Interference and Gene Delivery 6
-
- Nerve injury and regeneration 4
- Neuroscience and Neural Engineering 2
- Co-authors
- Marianna Földvári (12 shared papers)Nafiseh Nafissi (1 shared paper)Peter Kurre (5 shared papers)John T. Butler (2 shared papers)Antoine M. Hakim (1 shared paper)Chung-Hong Lee (2 shared papers)Hsin-Chang Yang (2 shared papers)Marjan Gharagozloo (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Blood (1 paper)Nanoscale (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- CanadaUnited StatesTaiwan
In The Last Decade
Ding-Wen Chen
17 papers receiving 410 citations
Peers
Comparison fields: 5 of 77
- Ophthalmology 44
- Molecular Biology 285
- Biomaterials 41
- Genetics 81
- Pharmaceutical Science 18
Countries citing papers authored by Ding-Wen Chen
This map shows the geographic impact of Ding-Wen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding-Wen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding-Wen Chen more than expected).
Fields of papers citing papers by Ding-Wen Chen
This network shows the impact of papers produced by Ding-Wen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding-Wen Chen. The network helps show where Ding-Wen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding-Wen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 202 | |
| 2 | 2020 | 46 | |
| 3 | 2023 | 39 | |
| 4 | 2023 | 16 | |
| 5 | 2024 | 15 | |
| 6 | 2008 | 14 | |
| 7 | 2018 | 14 | |
| 8 | 2016 | 14 | |
| 9 | 2015 | 13 | |
| 10 | 2016 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2022 | 6 | |
| 13 | 2015 | 5 | |
| 14 | 2018 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2007 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2022 | 0 |
About Ding-Wen Chen
Ding-Wen Chen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Hematology, Immunology and Ophthalmology, having authored 19 papers that have together received 413 indexed citations. Recurring topics across this work include Retinal Development and Disorders (7 papers), RNA Interference and Gene Delivery (6 papers), Nerve injury and regeneration (4 papers), Acute Myeloid Leukemia Research (3 papers), Immune cells in cancer (3 papers), Neuroscience and Neural Engineering (2 papers), Advanced Text Analysis Techniques (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Ophthalmology (44 citations), Molecular Biology (285 citations), Biomaterials (41 citations), Genetics (81 citations) and Pharmaceutical Science (18 citations). Ding-Wen Chen has collaborated with scholars based in Canada, United States and Taiwan. Frequent co-authors include Marianna Földvári, Nafiseh Nafissi, Peter Kurre, John T. Butler, Antoine M. Hakim, Chung-Hong Lee, Hsin-Chang Yang, Marjan Gharagozloo, Mohammad Kohandel and Sivabal Sivaloganathan. Their work appears in journals such as Journal of Controlled Release, Nanomedicine Nanotechnology Biology and Medicine, Blood, Nanoscale and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.